Search Results

Immune-Onc Therapeutics

Palo Alto, CA - is a cancer immunotherapy company dedicated to the discovery and development of novel myeloid checkpoint inhibitors for cancer patie…

Equity in Access Research Grants

Supporting the generation of evidence that will guide changes in healthcare policy and practice to ensure that all patients with and survivors of a bl…

Immunitas Therapeutics

Waltham, MA - Immunitas is committed to discovering and developing novel, differentiated therapeutics for patients with cancer using a discovery engin…

Rgenta Therapeutics

Cambridge, MA - Rgenta Therapeutics is developing a pipeline of oral, medicines with an initial focus on oncology and neurological disorders. Rgenta…

Student Mentorship and Research Training Program (SMART)

Providing medical students with opportunities to experience research alongside experienced blood cancer scientists.

Increase Access to Care and Services among Veterans with a Hematologic Malignancy

Fostering collaborative projects between Blood Cancer United and the VA to improve care, increase access to clinical trials, and provide enhanced supp…

Co-pay Compliance Program

Blood Cancer United is committed to operating its Assistance Program to the highest standard of compliance, adhering to all applicable federal regula…

Promoting diversity in clinical trials

People of color, young adults, older patients and patients in rural communities are less likely to enroll in a clinical trial. That not only means the…

Patient Referral Form

Provide your patients with additional resources and information about blood cancer. By completing Blood Cancer United’s Patient Referral Form, your pa…

Helping patients access out-of-network care

While facing the demanding physical, mental and emotional toll of blood cancer, many patients must also confront the daunting task of managing their o…

Discovery Grant Program (DGP)

Supporting cutting edge, innovative and discovery oriented research, to understand blood cancer properties and vulnerabilities and aimed toward advanc…

Promoting access to care for young survivors

Survivors of childhood cancer often experience physical and mental health needs for years after their active treatment ends. Compounded with other bur…

Strengthening the FDA

The U.S. Food & Drug Administration’s (FDA) mission has always centered on promoting and protecting the public’s health. Blood Cancer United holds FDA…

Securing manageable out-of-pocket costs for patients with private insurance

Thanks to advances in treatment, many diseases that were once considered fatal are now treated as manageable, chronic diseases. But to access those tr…

Tearing down barriers that block access to Medicaid

Ensuring that Medicaid can continue to provide critical coverage for cancer patients means defending against efforts to reduce coverage or create barr…

Acute myeloid leukemia (AML) research

Acute myeloid leukemia (AML) is an aggressive, disease in which the immature blood cells do not develop properly and grow uncontrollably. The AML ce…

Volunteer grants

Diffuse large B-cell lymphoma (DLBCL) research

Diffuse large lymphoma (DLBCL) is derived from white blood cells that grow in an uncontrolled, rapid manner and therefore require treatment. It is th…

Affimed

Heidelberg, Germany - Affimed is a company committed to giving patients back their innate ability to fight cancer by actualizing the untapped potent…

CMML Special Initiative

Customer support: Frequently asked questions

Get answers common customer support questions regarding donating, customizing fundraising pages, matching gifts, and much more.

The 100 days agenda: A patient-first blueprint

A collaboration among patient organizations.

Mantle Cell Lymphoma Research Initiative II (MCL2)

The Mantle Cell Lymphoma Research Initiative II supports targeted research to better understand disease mechanisms, develop more efficacious treatment…

Workplace giving campaigns

Waldenström macroglobulinemia (WM)

Waldenström macroglobulinemia (WM) is an uncommon cancer derived from a specific type of white blood cell, known as a type of plasma cell, and is some…